Early histopathological studies of diabetic choroids demonstrated loss of choriocapillaris (CC), tortuous blood vessels, microaneurysms, drusenoid deposits on Bruchs membrane, and choroidal neovascularization. The preponderance of histopathological changes were at and beyond equator. Studies from my lab suggest that diabetic choroidopathy is an inflammatory disease in that leukocyte adhesion molecules are elevated in the choroidal vasculature and polymorphonuclear neutrophils are often associated with sites of vascular loss. Modern imaging techniques demonstrate that blood flow is reduced in subfoveal choroidal vasculature. Angiography has shown areas of hypofluorescence and late filling that probably represent areas of vascular loss and/or compromise. Perhaps, as a result of vascular insufficiency, the choroid appears to thin in DC unless macular edema is present. Enhanced depth imaging (EDI-SD) OCT and swept source (SS) OCT have documented the tortuosity and loss in intermediate and large blood vessels in Sattler's and Haller's layer seen previously with histological techniques. The risk factors for DC include diabetic retinopathy, degree of diabetic control, and the treatment regimen. In the future, OCT angiography could be used to document loss of CC. Because most of the measurement and imaging are in the posterior pole, the severity of DC may be underappreciated in the published accounts of DC assessed with imaging techniques. However, it is now possible to document DC and quantify these changes clinically. This suggests that DC should be evaluated in future clinical trials of drugs targeting DR because vascular changes similar to those in DR are occurring in DC.
Introduction
Diabetes mellitus (DM) affects all small and large blood vessels in the body. Vascular dysfunction eventually results in tissue injury and degeneration. In the eye, the focus has always been the retinal changes that result in diabetic retinopathy (DR). However, it would seem logical that the choroidal vasculature would also be affected in DM and the choroid itself would degenerate resulting in diabetic choroidopathy.
The first report on diabetic choroidopathy, technically a diabetes-induced non-inflammatory degeneration of choroid, was from Hidayat and Fine (1985) in a small cohort of endstage, blind and painful diabetic eyes (Hidayat & Fine, 1985) . In this cohort, there was choriocapillaris (CC) dropout, luminal narrowing, and thickening of basement membranes with arteriosclerotic changes in some arteries. Fryczkowski performed vascular casts of a small cohort of diabetic eyes and analysed the choroidal vasculature with scanning electron microscopy (SEM) (Fryczkowski, 1988; Fryczkowski, Hodes, & Walker, 1989) . Loss of CC, large and intermediate blood vessel tortuosity, vascular hypercellularity and microaneurysms were documented with SEM in the human diabetic choroids.
Choroidal vascular loss
We documented the loss of functional CC in diabetic choroid using endogenous alkaline phosphatase (APase) enzyme histochemical activity. APase stains the entire choroidal vasculature; when enzyme activity is not present, there are no viable endothelial cells ( Fig. 1) (Lutty & McLeod, 2005; McLeod & Lutty, 1994) . Furthermore, choroidal neovascularization (CNV) has the greatest enzyme activity (Fig. 2) . Large fields of CC were dysfunctional in flat mount preparations of diabetic choroids using this histochemical analysis and the subjects were not endstage but rather represented all stages and types of diabetics, many without retinopathy (Lutty & McLeod, 2005; McLeod & Lutty, 1994) . The loss of functional choroidal blood vessels could be quantified using this method and image analysis. There were two types of loss: diffuse and focal or complete. Diffuse loss had capillary segments missing but no defined areas of absolute CC loss, whereas focal or complete (Fig. 1 ). The latter loss was able to be mapped and quantified and it was determined that there was four times more CC loss in diabetics than in older control, nondiabetic subjects (Cao, McLeod, Merges, & Lutty, 1998) . We hypothesize that loss in viable vasculature resulted in hypoxic RPE and outer retina, for which the CC is the sole source of oxygen and nutrients.
After the analysis of the vasculature in the flat perspective, the choroids were flat-embedded in glycol methacrylate, a transparent polymer from which two micron sections could be cut and then stained with tradition histochemical stains. Using PAS and hematoxylin staining, we observed accumulation of debris (PAS + ) on Bruchs membrane (BrMb) that was similar to basal laminar deposits (BLD) seen in age-related macular degeneration (AMD). The height of these deposits was quantified and related to the complete focal choriocapillaris degeneration (CCD) and choroidal neovascularization (CNV) (Fig. 3) . The more severe the diabetic choroidopathy the greater the deposit height (Cao et al., 1998) , suggesting that vascular insufficiency resulted in accumulation of debris on and in BrMb.
Etiology of choriocapillaris loss in diabetes
Diabetes is an inflammatory disease (Adamis, 2002) . Elevated levels of TNFa and IL1b had been measured in diabetic sera compared to sera from control subjects, reinforcing DM as an inflammatory disease (Lampeter et al., 1992) . Also, there are more activated leukocytes, especially polymorphonuclear neutrophils (PMNs), circulating in diabetics than in nondiabetics (WieruszWysocki et al., 1987) . It seemed logical that inflammation and inflammatory cells might contribute to loss of choroidal vasculature because Schmid-Schonbein had demonstrated accumulation of macrophages and PMNs in the retinas of diabetic rats (Schröder, Palinski, & Schmid-Schönbein, 1991) . In addition, the choroid is the site of many inflammatory pathologies like multifocal and serpiginous choroiditis, bird-shot choroidopathy, uveitis, and Vogt-Koyanagi-Harada disease.
Our focus was on PMNs because, once firmly adherent, they can undergo an oxidative burst that can damage endothelial cells . The yellow material is basal laminar deposit which accumulates non-reduced formazan reaction product. The CNV formation is surrounded by areas with severe CC loss. (B) A section through the CNV that was stained with PAS (pink) and hematoxylin (purple) demonstrates a pink basal laminar deposit ocer the CNV (arrow, intense blue APase activity) which has grown through a break in Bruchs membrane (arrowhead) (McLeod & Lutty, 1994) . (Springer, 1994) . PMNs from diabetics exhibit a great oxidative burst than nondiabetic PMNs (Baranao, Garberi, Tesone, & Rumi, 1987; Freedman & Hatchell, 1992) . Diabetic PMNs have a more rigid cytoplasmic membrane than nondiabetic PMNs making them more likely to be trapped in the microvasculature and cause capillary occlusion (Kelly, Barden, Tiedeman, & Hatchell, 1993) . Human choroids were incubated for APase and with nonspecific esterase (NSE; present in granulocytes and Mast cells) enzyme activity to evaluate PMNs and their association with CC loss (Cao et al., 1998; Lutty, Cao, & McLeod, 1997) . PMN numbers were significantly increased in diabetic choroid compared to aged controls and they were often associated with areas of pathology like capillary loss and CNV (Fig. 4) . There was a significant numerical correlation between CCD and the number of PMNs. There often queues of PMNs in APase À CC and CNV that lacked APase activity (Cao et al., 1998; Lutty et al., 1997) . This suggested that PMNs contributed to vaso-occlusive events and endothelial cell injury in diabetic choroid. PMNs adhere to the endothelial cell lining of blood vessels after rolling along that surface. P-selectin initiates the rolling and firm adherence occurs when the endothelial cells express intracellular adhesion molecule-1 (ICAM-1) and the activated PMNs express CD11/CD18 on their surface, which binds to ICAM-1 (Springer, 1994) . Both TNFa and IL1b are elevated in diabetic sera (Lampeter et al., 1992 ) and stimulate endothelial cell upregulation of adhesion molecules like P-selectin and ICAM-1. Immunohistochemistry demonstrated that endothelial cells in CC constitutively expressed ICAM-1, making CC perhaps the only capillary system where this adhesion molecule is constitutively expressed (McLeod, Lefer, Merges, & Lutty, 1995) . In diabetic choroids, ICAM-1 was significantly increased throughout the choroidal vasculature ( Fig. 5) (McLeod et al., 1995) . P-selectin was found in choroidal veins and venules of control subjects whereas it was observed in all choroidal vessels in diabetics. Upregulation of both adhesion molecules in diabetic choroid with elevated activated PMNs circulating in diabetics further supports PMN involvement in vasoocclusive events in diabetic choroid.
It is difficult, however, to demonstrate a causal relationship between PMNs and diabetic choroidopathy using postmortem human tissue. Fortunately, the studies of the Adamis lab demonstrate that the same scenario just proposed in human choroid occurs in diabetic rat retina. First, Lu and associates demonstrated that VEGF increases retinal vascular ICAM-1 expression (Lu et al., 1999) . When they blocked ICAM-1 with neutralizing antibodies, leukostasis and vascular leakage were prevented (Miyamoto et al., 1999) . Leukostasis was evaluated using the technique of Ogura where nucleated leukocytes are stained with intravenous acridine orange and an SLO was used to visualize them in the retinal and choroidal circulation (Ogura, 1999) . When Barouch et al. Fig. 3 . Thickness of Bruchs membrane deposits in diabetic subjects. The thickness of Bruchs membrane deposits (+/À SD) was assessed in subjects with no choriocapillaris degeneration or dropout (CCD) (white), CCD (Gray), and CCD and CNV (black). In group 2, nondiabetic aged control subjects with no measureable CCD, there was very little deposit. In group 1, the diabetic subjects had deposits that increased in thickness as areas with CCD became more effected, i.e. diffuse versus complete focal CCD. (B) Basal laminar deposits were significantly thicker in CCD areas in periphery, equator, and posterior pole and the thickest areas had CNV (asterisk = 0.05; dagger = 0.01) (Cao et al., 1998) . Fig. 4 . Alkaline phosphatase/nonspecific esterase (APase/NSE) double-labeled flat mounted choroids from an 88 year-old nondiabetic subject (A, top) and a 58 yearold type1 diabetic subject (B, bottom). APase activity (blue reaction product) is localized to viable choroidal blood vessels while NSE activity (red reaction product) labels polymorphonuclear neutrophils (PMNs) within choriocapillaris lumens and mast cells, which are larger and out of focus since they are found at the levels of Sattler's and Haller's layers. Ques of PMNs are present in degenerating segments of capillaries in the diabetic choroid (B). Note that PMNs are present within the choriocapillaris where APase activity stops . blocked CD18 they also prevented PMN adhesion and leukostasis (Barouch et al., 2000) . If they made ICAM-1 À/À or CD18 À/À mice diabetic, they prevented leukostasis and endothelial cell death normally observed in diabetic retina (Joussen et al., 2004) . Blocking TNFa with etanercept (a soluble TNFa receptor) inhibited leukostasis and endothelial cell injury in diabetes. Nonsteroidal anti-inflammatory drugs (high dose aspirin and COX2 inhibitor, meloxicam) prevented early diabetic retinopathy via suppression of TNF-a (Joussen et al., 2002) . Unfortunately, changes in choroidal leukostasis were not studied in these rodent experiments. They concluded from these studies that there is a central role for inflammation in DR (Joussen et al., 2004) .
Intra and extrachoroidal neovascularization in diabetic choroidopathy
Loss of CC in diabetic choroid could make those areas of choroid and overlying RPE hypoxic. When RPE are hypoxic they upregulate VEGF production, which stimulates angiogenesis (Shima et al., 1995) . We observed upregulation of vascular endothelial cell growth factor (VEGF) in diabetic choroid and it was associated with CC and CNV (Lutty, McLeod, Merges, Diggs, & Plouét, 1996) . In our studies of the diabetic choroid, we observed CNV that was associated with areas of CC loss ( Fig. 2A) (McLeod & Lutty, 1994) . The CNV was within and above BrMb and often appeared infarcted (endothelial cells were APase À ). In both studies that documented CNV in diabetic choroid, the CNV formations were at or peripheral to the equator (Cao et al., 1998; McLeod & Lutty, 1994) . We have also observed intrachoroidal neovascularization which we termed intrachoroidal microangiopathy (ICMA) (Fukushima, McLeod, & Lutty, 1997) . ICMA are cobweb-like neovascular formations that are deep in choroid, often near lamina fusca, the boundary between choroid and sclera. They have very high APase activity, can be as large as 4.6 mm 2 , and are connected to all levels of the choroidal vasculature (Fig. 6 ). They were observed in 20% of the diabetic subjects studied but their position in choroid was not necessarily related to CC dropout areas. The only microaneurysms we documented in diabetic choroid were in ICMA formations (Fukushima et al., 1997) .
Clinical evaluation of human diabetic choroidopathy with new imaging modalities
ICG angiography allowed choroidal vascular sufficiency to be evaluated and was the first imaging modality to detect changes in the diabetic choroid. Weinberger and Gaton observed a ''salt and pepper" pattern instead of ground glass with large hypofluorescent spots and large and small hyperfluorescent spots in nonproliferative diabetic retinopathy (NDR), which correlated with poor diabetic control (Weinberger et al., 1998 ). Shiragami and Shiraga saw similar irregularities in diabetic subjects using ICG and fluorescein angiography and the hypofluorescent spots were significantly associated with DR, while hyperfluorescent spots were significantly associated with elevated HbA1c (Shiragami, Shiraga, Matsuo, Tsuchida, & Ohtsuki, 2002) .
The advent of color Doppler imaging in the eye permitted blood flow to be assessed in diabetic eyes. The first study with this technique found that the central ophthalmic artery and vein had decreased flow in nonproliferative and background DR (Dimitrova et al., 2001) . Subfoveal measurements demonstrated significantly reduced choroidal blood volume and blood flow in proliferative DR using laser Doppler flowmetry (Schocket et al., 2004) . Another laser Doppler flowmetry study demonstrated a significant decrease in subfoveal choroidal blood flow in nonproliferative DR (NDR) (30%) compared with control and even more significantly in NDR with macular edema (ME) (48%) (Nagaoka et al., 2004) . The limitation on these studies is that CC flow can only be assessed in subfovea because there is no retinal vascular interference in fovea. Therefore, we only have measurements in a very small area of choroid.
Recent imaging studies have focused on choroidal thickness, certainly a characteristic of diabetic choroidopathy or atrophy, but conclusions about changes in choroidal thickness in diabetics varies. Thinner diabetic choroids were found with increased microalbuminuria (Campos, Campos, Martins, Ambrosio, & Silva, 2016) . A significantly thinner subfoveal choroid was found in all groups of type 2 Diabetic eyes compared to healthy eyes using 1060 nm OCT (Esmaeelpour et al., 2011) . That study and another a year later found significant reduction in choroidal thickness in diabetic patients without retinopathy (Esmaeelpour et al., 2011; Querques et al., 2012) . However, Hua et al. found greater choroidal area in diabetic choroid using enhanced depth (EDI) OCT (Hua, Liu, Wang, & Chen, 2013) . Also, the change in thickness in diabetic macular edema (DME) is still controversial in that both thickening and thinning have been observed. One problem with these recent studies is that treatments were not considered. Both anti-VEGF and panretinal photocoagulation caused a decrease in choroidal thickening perhaps due to reduction in permeability of the choroidal vasculature (Melancia, Vicente, Cunha, Abegao Pinto, & Ferreira, 2016 ). An in depth discussion of these differences is reviewed by Melancia et al. and Campos et al. (Campos et al., 2016; Melancia et al., 2016) . The consensus from these reviews is that choroid thins in diabetic eyes without DME and treatment of DME with anti-VEGF causes thinning of choroid (Melancia et al., 2016) in agreement with Esmaeelpour et al. and Querques et al. (Esmaeelpour et al., 2011; Querques et al., 2012) . There is also controversial data on untreated DME. Kim et al. observed thicker subfoveal choroid using EDI-OCT (Kim, Lee, Joe, Kim, & Yoon, 2013) while Regatieri et al. found thinner than normal subfoveal choroid in untreated DME using SD-OCT (Regatieri, Branchini, Carmody, Fujimoto, & Duker, 2012) . The latter study agrees with Gerendas et al. who found reduced choroidal thickness in diabetics with DME using 3-dimentional SD-OCT (Gerendas et al., 2014) . The difference may be the technology used to image the choroids.
Optical coherence tomography (OCT) has also contributed to our understanding of diabetic choroidopathy. Hua and associates used enhanced depth imaging spectral domain OCT (EDI-SD OCT) tomography and ICG angiography to study DC and observed hypofluorescent areas and late choroidal nonperfusion regions (Hua et al., 2013) . These areas are potentially areas of choroidal nonperfusion or poor perfusion and, therefore, areas of choroidal hypoxia, which is a risk for DC with DR. Swept source (SS)-OCT has a longer wavelength, faster scanning speed, and invisible scanning light. This achieves better three-dimensional choroidal images and better evaluation of Sattler's and Haller's layer blood vessels. Ferrara et al. used en face SS-OCT and observed choroidal vascular remodeling in all DM patients corresponding to irregular, tortuous and beaded choroidal vessels with focal dilatations and remodeling (Fig. 7) (Ferrara, Waheed, & Duker, 2016) . Enface SS- ''c" in (A) . Notice that these ICMA capillaries are intensely blue and are located in outer choroid at the level of Haller's layer where there are normally no capillaries (Fukushima et al., 1997) .
[section in (C) stained with PAS (pink) and hematoxylin (purple) in addition to blue APase reaction product.] OCT at 1050 nm demonstrated loss of vessels in Sattler's layer in 30% of the diabetic choroids and focal narrowing in vessels in Haller's layer in 51% of the diabetic eyes, vascular stumps and aneurysmal changes in Haller's layer (Murakami et al., 2016) . Loss of vessels was related significantly to increased HbA1c.
Conclusions
Our first insights into DC were from the study of Hidayat and Fine in 1985 (Hidayat & Fine, 1985) . Subsequent histopathological studies from my lab (Cao et al., 1998; Lutty, 2000; McLeod & Lutty, 1994) and Fryczkowski (Fryczkowski, Sato, & Hodes, 1988; Fryczkowski, 1988; Fryczkowski et al., 1989) reported loss of choriocapillaris, tortuous blood vessels, microaneurysms, drusenoid deposits on Bruch's membrane, and choroidal neovascularization. The preponderance of histopathological changes shown in the Figures herein and our studies cited were predominantly at and beyond equator. Our subject population in those studies was a mixture of diabetics: approximately 1/3 type 1 and 2/3 type 2 diabetics. We have also observed that diabetic choroidopathy is an inflammatory disease in that leukocyte adhesion molecules are elevated and PMNs are often associated with sites of vascular loss (Cao et al., 1998; Lutty et al., 1997) . Modern imaging techniques, although confined predominantly to subfoveal choroid, have elucidated the extent of choroidopathy clinically and re-affirm the findings of the histopathological studies. Blood flow is reduced in subfoveal choroidal vasculature (Nagaoka et al., 2004; Schocket et al., 2004) and areas of hypofluorescence and late filling undoubtedly represent areas of vascular loss and/or compromise (Shiragami et al., 2002; Weinberger et al., 1998) . Perhaps, as a result of vascular insufficiency, the choroid appears to thin in DC unless macular edema is present (Campos et al., 2016; Melancia et al., 2016) . EDI-SD OCT and SS OCT have documented the tortuosity and loss in intermediate and large blood vessels in Sattler's and Haller's layer (Ferrara et al., 2016; Hua et al., 2013; Murakami et al., 2016) seen previously with histological techniques. The risk factors for DC include diabetic retinopathy, degree of diabetic control, and the treatment regimen (Shiragami et al., 2002) . Future studies should also employ OCT angiography because loss in CC flood flow could be documented with this technique. In view of recent reports demonstrating the distensibility in choroid (Arora, Jefferys, Maul, & Quigley, 2012) and diurnal changes in choroidal thickness (Chakraborty, Read, & Collins, 2011; Tan, Ouyang, Ruiz, & Sadda, 2012) , longitudinal studies where the subjects are imaged with the same imaging modalities at the same time of day should be done to clarify the choroidal thickness in different diabetic groups. Because most of the measurement and imaging are in the posterior pole, the severity of DC may be underappreciated in the published accounts of DC assessed with imaging techniques. However, it is now possible to document DC and quantify these changes clinically. This suggests that DC should be evaluated in future clinical trials of drugs target- ing DR because vascular changes similar to those in DR are occurring in DC, which could affect visual function in DR.
